Latest News and Press Releases
Want to stay updated on the latest news?
-
Jay Schwartz assumes the role of CEO as Blueroot Health enters its next phase of growth.
-
Apothecare calls for medical cannabis education to be integrated into clinical training in response to new guidance from Health Canada.
-
New data on Ashwa.30 gives clinicians objective markers to support stress resilience, physical performance, and recovery.
-
Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications Press releaseCopenhagen — February 10, 2026 —...
-
Belleville, Illinois, Feb. 09, 2026 (GLOBE NEWSWIRE) -- During American Heart Month, Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation is...
-
Les maladies cardiaques sont la première cause de décès prématuré chez les Canadiennes. TLM en rouge (13 fév.) est une invitation à changer les choses.
-
Wear Red Canada (Feb. 13) spotlights women’s heart disease—the leading cause of premature death for women in Canada—urging awareness and action.
-
Did Ardent Health, Inc. Mislead Investors about its Collectability Issues? Contact BFA Law about its Pending Securities Fraud Class Action
-
Le rilzabrutinib de Sanofi a été désigné comme thérapie innovante aux États-Unis et comme médicament orphelin au Japon pour le traitement de l’anémie hémolytique auto-immune à anticorps chauds Le...
-
The US and Japan granted breakthrough therapy/orphan status to rilzabrutinib for wAIHA, a rare blood disorder marked by the destruction of red blood cells